<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00906867</url>
  </required_header>
  <id_info>
    <org_study_id>KGU-62/09</org_study_id>
    <nct_id>NCT00906867</nct_id>
  </id_info>
  <brief_title>Pulmonary Function Test, Bronchial Hyperresponsiveness and Quality of Life in Patients With Vocal Cord Dysfunction (VCD)</brief_title>
  <acronym>VCD</acronym>
  <official_title>Pulmonary Function Test, Bronchial Hyperresponsiveness and Quality of Life in Patients With Vocal Cord Dysfunction (VCD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vocal cord dysfunction is a rare clinical picture. It is labeled as a sudden and threatening
      dyspnea. Patients with VCD may also present cough, hoarseness, wheezing, and chest tightness,
      but an inspiratory stridor is the most common symptom. For this reason, such patients are
      often misdiagnosed with refractory asthma, because of poor response to steroids and
      bronchodilators. Diagnosis is suspected on clinical grounds and is confirmed with
      laryngoscopy. The therapy consists of education, speech therapy and if necessary
      psychotherapy. The purpose of the investigators' study is to characterize children,
      adolescents, and young adults with VCD, and the evaluation of predictors as atopy, bronchial
      hyperresponsiveness, and psychiatric features.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      VCD appears to be significantly more common among females. The episode of dyspnea underlies
      the paradoxical, intermittent adduction of the vocal cords during inspiration. Methacholine
      challenge testing combined with laryngoscopy is useful in differentiating vocal cord
      dysfunction from asthma during the asymptomatic period.

      In one visit patients will be characterized with a questionnaire based on the ISAAC
      questionnaire. Furthermore, FeNO, eCO, skin prick testing and total serum IgE will be
      examined. The psychiatric condition of patients will be determined by CBCL/6-18 and YSR/11-18
      behavior questionnaires. After initial fiberoptic laryngoscopy and pulmonary function
      testing, bronchoprovocation is performed using nebulized methacholine at increasing doses,
      until a 20% decline in the forced expiratory volume in 1 second is achieved (PD20FEV1). Each
      methacholine testing will be followed by a second laryngoscopy and pulmonary function
      testing. The visualization of paradoxical vocal cord motion during inspiration will be
      recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Characterization of vocal cord dysfunction, and evaluation of predictors as atopy, bronchial hyperresponsiveness, and psychiatric behavior.</measure>
    <time_frame>one day</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">25</enrollment>
  <condition>Dyspnea</condition>
  <arm_group>
    <arm_group_label>Vocal cord dysfunction</arm_group_label>
    <description>Patients with suspicion of VCD</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Methacholine challenge testing</intervention_name>
    <description>Nebulized methacholine administered at the following doses: 0,1 mg/0,4 mg/0,8 mg/1,6 mg</description>
    <arm_group_label>Vocal cord dysfunction</arm_group_label>
    <other_name>Aerosol Provocation System (Cardinal Health GmbH)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rhino-laryngoscopy</intervention_name>
    <description>Topical anesthesia (Xylocain Pump spray) followed by transnasal fiberoptic laryngoscopy with a flexible fiberoptic laryngoscope.</description>
    <arm_group_label>Vocal cord dysfunction</arm_group_label>
    <other_name>ENF-V2 laryngoscope Olympus</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, total IgE
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatients of departement of Pediatric Pulmonology and Allergology.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent

          -  Age 7 to 30 Years

          -  Documented VCD or strong suspicion of VCD

          -  Pulmonary function test: FEV1 (% pred.) â‰¥ 70%

        Exclusion Criteria:

          -  Age &lt; 7 and &gt; 30 Years

          -  Pulmonary function test: FEV1 (% pred.) &lt; 70%

          -  Others chronic diseases or infections (e.g., HIV, tuberculosis, malignancy)

          -  Pregnancy

          -  Documented alcohol, substance, and/or drug abuse

          -  Incapability to perform all study procedure

          -  Current participation in another clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Zielen, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Goethe University, Frankfurt, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Goethe University Hospital</name>
      <address>
        <city>Frankfurt</city>
        <state>Hesse</state>
        <zip>60596</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Perkins PJ, Morris MJ. Vocal cord dysfunction induced by methacholine challenge testing. Chest. 2002 Dec;122(6):1988-93.</citation>
    <PMID>12475837</PMID>
  </reference>
  <reference>
    <citation>Guss J, Mirza N. Methacholine challenge testing in the diagnosis of paradoxical vocal fold motion. Laryngoscope. 2006 Sep;116(9):1558-61.</citation>
    <PMID>16954978</PMID>
  </reference>
  <reference>
    <citation>Husein OF, Husein TN, Gardner R, Chiang T, Larson DG, Obert K, Thompson J, Trudeau MD, Dell DM, Forrest LA. Formal psychological testing in patients with paradoxical vocal fold dysfunction. Laryngoscope. 2008 Apr;118(4):740-7. doi: 10.1097/MLG.0b013e31815ed13a.</citation>
    <PMID>18182970</PMID>
  </reference>
  <reference>
    <citation>Sandage MJ, Zelazny SK. Paradoxical vocal fold motion in children and adolescents. Lang Speech Hear Serv Sch. 2004 Oct;35(4):353-62. Review.</citation>
    <PMID>15609638</PMID>
  </reference>
  <reference>
    <citation>Loughlin CJ, Koufman JA. Paroxysmal laryngospasm secondary to gastroesophageal reflux. Laryngoscope. 1996 Dec;106(12 Pt 1):1502-5.</citation>
    <PMID>8948611</PMID>
  </reference>
  <reference>
    <citation>Newman KB, Mason UG 3rd, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1382-6.</citation>
    <PMID>7551399</PMID>
  </reference>
  <reference>
    <citation>Mikita CP, Mikita JA. Allergic bronchopulmonary aspergillosis. Allergy Asthma Proc. 2006 Jan-Feb;27(1):82-4.</citation>
    <PMID>16598999</PMID>
  </reference>
  <reference>
    <citation>Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000 Jan;161(1):309-29.</citation>
    <PMID>10619836</PMID>
  </reference>
  <reference>
    <citation>Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, Mitchell EA, Pearce N, Sibbald B, Stewart AW, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995 Mar;8(3):483-91.</citation>
    <PMID>7789502</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 20, 2009</study_first_submitted>
  <study_first_submitted_qc>May 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2009</study_first_posted>
  <last_update_submitted>March 2, 2017</last_update_submitted>
  <last_update_submitted_qc>March 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Johannes Schulze MD</investigator_full_name>
    <investigator_title>Cosultant Pediatric Allergy and Pulmonolgy</investigator_title>
  </responsible_party>
  <keyword>Vocal cord dysfunction</keyword>
  <keyword>Laryngoscopy</keyword>
  <keyword>Methacholine challenge</keyword>
  <keyword>Pulmonary function testing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspnea</mesh_term>
    <mesh_term>Bronchial Hyperreactivity</mesh_term>
    <mesh_term>Vocal Cord Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methacholine Chloride</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

